Desmin (a low molecular weight dermatan sulphate) versus heparin in the treatment of patients with deep venous thrombosis

European Journal of Clinical Pharmacology

Volumn 54, Issue 2, 1998, Pages 133-139

  Von Kemp, K ^a   Jochmans, K ^b   Van Tussenbroek, F ^b   Debruyne, H ^c   Van Den Brande, P ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c Cresec International SA   (Belgium)

Author keywords

Desmin; Vein thrombosis

Indexed keywords

CODEINE; DESMIN; HEPARIN; PARACETAMOL;

ADULT; ARTICLE; BLOOD CLOTTING TEST; CLINICAL ARTICLE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PAIN; PHLEBOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION TESTS; DESMIN; FEMALE; HEPARIN; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; THROMBOPHLEBITIS; TREATMENT OUTCOME;

EID: 0031896819     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050434     Document Type: Article

References (23)

1. Prandoni P, Lensing AWA, Büller HR, Carta M, Cogo A, Vigo M, Casara D, Ruol A, Ten Cate W (1992) Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep vein thrombosis. Lancet 339: 441-445
2. Hull RD, Raskob GE, Pineo GF, Green D, Trowbridge AA, Elliot G, Lerner RG, Hall J, Sparling T, Bretell HR, Norton J, Carter CJ, George R, Merli G, Ward J, Mayo W, Rosenbloom D, Brand R (1992) Subcutaneous low-molecular-weight compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 326: 975-982
3. Levine M, Gent M, Hirsch J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M, Geerts W, Kassis J, Desjardins L, Cusson J, Cruickshank M, Powers P, Brien W, Haley S, Willan A (1996) A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334: 677-681
4. Koopman MMW, Prandoni P, Piovella F, Ockelford PA, Brandjes DPM, Van der Meer J, Gallus AS, Simonneau G, Chesterman C, Prins MH, Bossuyt PMM, De Haes H, Van den Belt AGM, Sagnard L, d'Azemar P, Bullers HR for the Tasman Study Group (1996) Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital, as compared with subcutaneous low-molecular weight heparin administered at home. N Engl J Med 334: 682-687
5. Goldhaber SZ, Buring JE, Lipnick RE, Hennekens CH (1984) Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 76: 393-397
6. Comerota AJ, Aldridge SC (1993) Thrombolytic therapy for deep venous thrombosis: A clinical review. Can J Surg 36: 359-364
7. Tollefsen DM, Pestka CA, Monafo WJ (1983) Activation of heparin cofactor II by dermatan sulphate. J Biol Chem 258: 6713-6716
8. Ofosu FA, Modi GJ, Smith LM, Cerskus AL, Hirsh J, Blajchman MA (1984) Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Blood 64: 742-747
9. Desnoyers P, Bara L, Samama M (1989) Dermatane-sulfate et prevention des thromboses veineuses experimentales. Pathol Biol (Paris) 37: 759-67
10. Sie P, Ofosu F, Fernandez F, Buchanan MR, Petitou M, Boneu B (1986) Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides. Br J Haematol 64: 707-714
11. Scully MF, Ellis V, Kakkar VV (1988) Effect of oversulphated chondroitin and dermatansulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II Biochem J 254: 547-551
12. Abbadini M, Zhu GJ, Maggi A, Pangrazzi J, Donati MB, Mussoni L (1987) Dermatan sulphate induces plasminogen activator release in the perfused rat hindquarters. Blood 70: 1858-1860
13. Barbanti M, Calanni F, Babbini M, Bergonzini G, Parma B, Marchi E (1993) Antithrombotic activity of Desmin 370. Comparison with high molecular weight dermatan sulfate. Thromb Res 71: 417-422
14. Legnani C, Palareti G, Biagi R, Ludovici S, Maggiore L, Milani MR, Coccheri S (1994) Acute and chronic clotting and fibrinolytic effect of a new low molecular weight dermatan sulfate (Desmin 370) in healthy subjects. Eur J Clin Pharm 47: 247-252
15. Dettori AG, Milani MR, Manotti C, Zamboni V, Palazzini E, Barbanti M (1995) Pharmacology of Desmin (low molecular weight dermatan sulfate) in healthy volunteers following intravenous bolus administration of different dosages (200, 400, 800 mg). Thromb Res 79: 249-260
16. Barbanti M, Calanni F, Milani MR, Marchi E, Semeraro N, Colucci M (1993) Therapeutic effect of low molecular weight dermatan sulfate (Desmin 370) in rat venous thrombosis. Evidence for an anticoagulant-independent mechanism. Thromb Haemost 69: 147-151
17. Van Ryn-McKenna J, Ofosu FA, Gray E, Hirsh J, Buchanan MR (1989) The effects of dermatan sulphate and heparin on inhibition of thrombus growth in vivo. Ann N Y Acad Sci 556: 304-312
18. Blardi P, Messa GL, Urso R, Di Perri T (1993) Pharmacokinetics and pharmacodynamics of dermatan sulfate after intravenous and intramuscular administration to healthy volunteers. Int J Clin Pharmacol Res 13: 231-238
19. Agnelli G, Cosmi B, Di Filippo P, Ranucci V, Veschi F, Longetti M, Renga C, Barzi F, Gianese F, Lupatelli L, Rinonapoli E, Nenci G (1992) A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. Thromb Haemost 67: 203-208
20. Prandoni P, Meduri F, Cuppini S, Toniato A, Zangrandi F, Polistena P, Gianese F, Maffei Faccioli A (1992) Dermatan sulphate: a safe approach to prevention of postoperative deep vein thrombosis. Br J Surg 79: 505-509
21. Marder VJ, Soulen RL, Atichartakarn V, Budzynski AZ, Parulekar S, Kim JR, Edward N, Zahavi J, Algazy KM (1977) Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med 89: 1018-1029
22. Dupouy D, Sié P, Dol F, Boneu B (1988) A simple method to measure Dermatan Sulphate at sub-microgram concentrations in plasma. Thromb Haemost 60: 236-239
23. Imbimbo BP, Sié P, Agnelli G, Saivin S, Dupouy D, Damiani M, Houin G, Gianese F (1994) Intramuscular dermatan sulfate MF701 in patients with hip fracture: relationship between pharmacokinetics and antithrombotic efficacy. Thromb Haemost 71: 553-557